R JOHN FLETCHER
CIK 1215024 · last filed 2026-07-06
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$2.88M
Companies
8
Total Filings
149
Lifetime Open-Market Net
-$3.05M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| CLPT | Director | 131,011 | $14.57 | $1.91M | $0 | 37 | 2026-07-06 |
| KRMD | Director | 232,157 | $3.40 | $789.3K | $207.6K | 31 | 2026-07-01 |
| OptiNose, Inc. (OPTN) Delisted | Director | — | $9.60 | — | $0 | 4 | 2025-05-21 |
| Vyant Bio, Inc. (VYNT) Delisted | Director | 29,955 | $0.19 | $5.8K | $101.8K | 9 | 2023-01-19 |
| ACLS | Director | 1,354 | $132.65 | $179.6K | -$2.96M | 23 | 2021-02-17 |
| SPECTRANETICS CORP (SPNC) Delisted | Director | 141,697 | — | — | -$403.2K | 17 | 2017-06-12 |
| Adhera Therapeutics, Inc. (MRNAD) Delisted | Director | — | — | — | $0 | 1 | 2011-09-07 |
| PANACOS PHARMACEUTICALS, INC. (PANC) Delisted | Director | — | — | — | $0 | 3 | 2008-06-30 |
Recent Filings · Page 4 of 15
149 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2023-10-03 | KRMD | Grant (A) | +8,226 | $22.5K | EDGAR |
| 2023-10-03 | CLPT | Grant (A) | +1,153 | $5.8K | EDGAR |
| 2023-07-05 | CLPT | Grant (A) | +798 | $5.8K | EDGAR |
| 2023-07-05 | KRMD | Grant (A) | +6,465 | $22.5K | EDGAR |
| 2023-06-09 | OptiNose, Inc. (OPTN) Delisted | Grant (A) | — | $0 | EDGAR |
| 2023-05-26 | CLPT | Grant (A) | — | $0 | EDGAR |
| 2023-04-05 | KRMD | Grant (A) | +5,281 | $22.5K | EDGAR |
| 2023-04-04 | CLPT | Grant (A) | +684 | $5.8K | EDGAR |
| 2023-04-03 | KRMD | Grant (A) | +5,281 | $22.5K | EDGAR |
| 2023-01-19 | Vyant Bio, Inc. (VYNT) Delisted | Grant (A) | +4,368 | $0 | EDGAR |
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.